INTRODUCTION
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MATERIALS AND METHODS
Protocols described herein were approved by the North Dakota State University Institutional animal care and use committee.
Animals
Crossbred Angus heifers (n = 49, ~15 mo of age; average initial BW = 324.9 kg) were exposed to the 5-d CO-Synch + CIDR (Eazi-Breed CIDR Cattle Insert, Nasko, Fort Atkinson, WI) estrus synchronization protocol. Six heifers were not inseminated to serve as nonpregnant (NP) controls but underwent ovariohysterectomy for tissue collections on d 16 of the synchronized estrous cycle. The remaining heifers (n = 6 to 9/d of gestation/treatment) were bred by AI to a common sire at 12 h after observed estrus and ovariohysterectomized at d 16, 34, or 50 of gestation (McLean et al., 2016) .
Diet and Housing
Heifers were housed at the North Dakota State University Animal Nutrition and Physiology Center. Heifers were acclimated to individual bunk feeding (American Calan, Northwood, NH) for 2 wk before the beginning of the trial. Immediately following AI, heifers were randomly assigned to 1 of 2 treatment groups. Control heifers (CON) received 100% of NRC (2000) requirements for 0.45 kg/d gain to reach 80% of mature BW at first calving. Restricted heifers (RES) were placed on a 40% global nutrient restriction, which was accomplished by reducing total diet delivery to 60% of CON. The diet was delivered as a total mixed ration (48.37% DM, 5.28% CP, 6.77% ash, and 29.43% NDF on a DM basis) of grass hay, corn silage, alfalfa haylage, and grain supplement. Dried distillers grains (87.5% DM, 8.2% ash, 31.3% CP, and 53.4% NDF on a DM basis) were supplemented on an individual basis to meet CON ADG and were restricted 40% for RES heifers.
Sample Collection
Immediately following ovariohysterectomy, uteroplacental tissues (caruncle, CAR; intercaruncular endometrium, ICAR; fetal membrane [chorioallantois], FM) were obtained from the uterine horn containing the conceptus, as previously described (Grazul-Bilska et al., 2010 . Fetal membranes were collected only from pregnant heifers because of a lack of FM in NP controls. Once collected, all tissues were flash frozen in liquid nitrogen-cooled isopentane and stored at −80°C.
Real-Time Quantitative PCR
Total RNA was extracted and purified using an Aurum Total RNA Mini Kit (Bio-Rad, Hercules, CA), and cDNA was synthesized utilizing an iScript cDNA Synthesis Kit (Bio-Rad). The RNA concentration was determined using the Take3 module of a Synergy H1 Microplate Reader (BioTek, Winooski, VT). Gene expression was quantified using a 7500 Fast, Real-Time PCR System (Applied Biosystems, Grand Island, NY) with SYBR Green Master Mix (Bio-Rad) in duplicate. Relative expression was calculated using the ΔΔCt method (Livak and Schmittgen, 2001 ) with β-actin as a reference gene because of the consistency of expression across day of gestation and uteroplacental tissue type compared with other reference genes investigated, such as GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase), YWHAZ (Tyrosine 3-Monooxygenase/ Tryptophan 5-Monooxygenase Activation Protein Zeta), TBP (TATA-Box Binding Protein) and SDHA (Succinate Dehydrogenase Complex Flavoprotein Subunit A). The average of NP expression was used as the control within each tissue, with the exception of FM, in which NP endometrium sample was used as the control.
Primer Selection and Validation
Coding sequences for GLUT3 (Genbank accession number NM_174603.3) and GLUT14 (Genbank accession number NC_007316.5) were aligned using CLUSTALW (EBI, Hinxton, UK). The GLUT3 primer sequences were as follows: forward, CAAGT-CACAGTGCTAGAGTCTTTC, and reverse, GGA-GAG CTGGAGCATGATAGAGAT (Mattmiller et al., 2011) . The primers for GLUT14 were designed after alignment with GLUT3 and were chosen on the basis of the area of greatest SNP (bold bases): forward, TATG CTTTGGAAAAGTGGTCAGGAACC, reverse, GATG GAGAAGGAACCGATCATA. Each primer pair was validated using the 7500 Fast Real-Time PCR system in CAR, ICAR, and FM from heifers on d 16, 34, and 50 of gestation to ensure product specificity. To confirm assay specificity, the end products of the quantitative PCR (qPCR) reaction were sequenced. The PCR products were purified using a Purelink Quick PCR Purification Kit (Invitrogen, Carlsbad, CA) and then sequenced using SimpleSeq (Eurofins MWG Operon LLC, Louisville, KY). Sequences from each tissue were aligned using MacVector version 14.5 (MacVector Inc., Apex, NC) to ensure products were GLUT3 and GLUT14 (Fig. 1) .
Statistical Analysis
Data were analyzed using the GLM procedure of SAS 9.3 (SAS Inst. Inc., Cary, NC) with day, treatment, and day × treatment in the model. If no significant interactions were present, main effects of maternal nutrition and day of gestation were reported. Means were separated using LSMEANS, and P-values ≤ 0.05 were considered significant. Additionally, contrasts were conducted comparing the gene expression for NP vs. pregnant heifers, d 16 vs. d 34 and 50 (preimplantation vs. postimplantation), and d 34 vs. d 50 using the GLM procedure of SAS, with P-values ≤ 0.05 being considered significant.
RESULTS

GLUT3
There was no day × treatment interaction for GLUT3 in CAR, ICAR, or FM. Expression of GLUT3 in CAR was greater (P = 0.03) on d 50 than on d 16 (10.38 vs. 2.59 respectively, SEM = 2.86; Table 1 ). In ICAR, GLUT3 was greatest (P = 0.02) on d 50 compared with d 16 and 34 of gestation (3.20 vs. 1.96 and 1.14, respectively, SEM = 0.70; Table 1 ). Conversely, in FM, GLUT3 was greater (P = 0.04) on d 16 than on d 50. Expression of GLUT3 in CAR was greater (P = 0.05) in pregnant heifers than in NP controls. Additionally, expression of GLUT3 in CAR was greater (P = 0.01) on d 34 and 50 compared with d 16. Glucose transporter GLUT3 tended (P = 0.08) to be greater in CON heifers in ICAR than in RES heifers.
GLUT14
There was no day × treatment interaction for GLUT14 in CAR, ICAR, or FM. Expression of GLUT14 in CAR was greater (P < 0.05) on d 50 than on d 16 and 34 (9.27 vs. 1.53 and 2.65, respectively, SEM = 2.93; Table 1 ). In CAR, GLUT14 was greater (P = 0.02) on d 50 than on d 34 and tended (P = 0.07) to be greater on d 34 and 50 than on d 16 (Table 1 ). In ICAR, GLUT14 tended (P = 0.09) to be greater on d 16 than on d 34 (Table 1 ). There were no main effects of day of gestation or treatment in FM.
DISCUSSION
This study is the first to confirm the presence of GLUT14 in bovine uteroplacental tissues (using both qPCR and Sanger sequencing to ensure product specificity) on d 16, 34, and 50 of gestation. This study also validates previous data produced by Crouse et al. (2015) isolating GLUT3 expression in beef heifer uteroplacental tissues on d 16, 22, 28, 34, 40, and 50 of gestation.
Glucose is a major source of energy for the conceptus and placenta during early gestation and is required for the maintenance of normal fetal metabolism and growth (Hay, 2006; Dunlap et al., 2015) . Glucose must be transported into the uterine lumen and conceptuses via nutrient transporters in the endometrium and developing placenta. The main glucose transporters previously isolated in the ruminant uterus are GLUT1 (SLC2A1), GLUT4 (SLC2A4), SGLT1 (SLC5A1), and SGLT11 (SLC5A11), of which GLUT1 and GLUT4 are sodium-independent glucose transporters and SGLT1 and SGLT11 are sodium dependent (Gao et al., 2009 ). In sheep, GLUT1 mRNA was most abundant in luminal epithelium and superficial glandular epithelium. In rats, GLUT3 was found to be in the uterine stoma and dense connective tissue, GLUT4 mRNA was most abundant in luminal epithelium and glandular epithelium, SGLT1 mRNA was most abundant in luminal and glandular epithelium, and SGLT11 mRNA was most abundant in uterine glandular epithelium (Gao et al., 2009) . The main glucose transporters of the ruminant placenta are GLUT1 and GLUT3, with GLUT4 (insulin dependent) and GLUT8 being less abundant (Zhang et al., 2015) . The abundance of mRNA expressed for GLUT1 is found in the basal trophoblast membrane of the placenta (Hay, 2006) , and GLUT3 mRNA is more abundant in the microvillous membrane (Korgun et al., 2001) ; GLUT4 mRNA was determined to be more abundant in fibroblasts from amnion and chorion, and GLUT8 mRNA was found to be most abundant in the chorionic epithelial later (Zhang et al., 2015) . The glucose transporters of interest in this study are the high-affinity, high-capacity GLUT3 and its duplicon, GLUT14. Glucose transporter GLUT3 is unique in comparison with other glucose transporters in uteroplacental tissues in that a mutation of the GLUT3 gene in mice caused early embryonic mortality, indicating that the amount of glucose being transported by GLUT3 simply could not be made up for by other uteroplacen- tal glucose transporters, including GLUT1, GLUT4, and GLUT8 (Ganguly et al., 2007) . This is due to the transport capacity of GLUT3 at 1.5 mM (Thorens and Mueckler, 2010) in comparison to GLUT1 at 6.9 mM (Burant and Bell, 1992 ) and GLUT4 at 4 mM (Nishimura et al., 1993) with the lower k m (Michaelis Constant) equating to greater transport capacity. Additionally, isolating the presence of GLUT14 expression in bovine uteroplacental tissues indicates the uterine and placental need for another potentially high capacity glucose transporter. No research has been found determining the transport capacity of GLUT14 to determine if it is comparable to GLUT3. However, like other GLUT transporters, GLUT14 contains 12 putative membrane-spanning helices along with sugar transporter signature motifs that have previously been shown to be essential for sugar transport activity (Wu and Freeze, 2002) . This indicates that GLUT14 should be able to transport glucose, and establishment of its transport capacity would more greatly determine its role in glucose transport in the bovine uteroplacenta. Additional work localizing the transporters using immuno histochemistry or RNA fluorescent in situ hybridization would allow for determination of transporter location (e.g., caruncular or glandular).
It is of great interest that even though GLUT14 arose as a duplication of GLUT3, the expression patterns between the 2 transporters differ. In CAR, both GLUT3 and GLUT14 shared similar patterns of expression, increasing from d 16 to 50 of gestation. In ICAR, GLUT3 transporter expression increased to d 50, whereas GLUT14 tended to be greater on d 16 of gestation. In FM, GLUT3 expression decreased to d 50 of gestation, whereas there was no effect of day of gestation for GLUT14. This is possibly indicative of differential transport capacity or preferential use of 1 transporter isoform over another. Specific expression of GLUT3 and GLUT14 in CAR demonstrates the establishment of a known high-capacity transporter (GLUT3), and its duplicon on the site of the placentome. Comparison of the overall expression of both transporters will need to be conducted to determine preferential use and therefore further elucidate the functions of GLUT14 and GLUT3 in bovine uteroplacental tissues. 1 GLUT3 = glucose transporter solute carrier family 2 member 3 (SLC2A3). GLUT14 = glucose transporter solute carrier family 2 member 14 (SLC2A14).
2 CAR = caruncles, ICAR = endometrium not including caruncles, FM = chorioallantois.
3 Dietary Trt = nutritional treatment of the heifer; CON = heifers fed 100% of NRC requirements to gain 0.45 kg daily. RES = heifers fed 60% of control diets achieved by reducing intake. 4 Number of days after insemination.
5 Average Trt expression across day of gestation within Nutritional Treatment.
6 Average SEM was used within gene. Glucose transporters are essential in tissues requiring high concentrations of glucose for energy because of their ability to transport glucose at a rate 10,000 times higher than passive diffusion across the lipid bilayer of the cell (Elbrink and Bihler, 1975) . Although fructose, not glucose, is the main hexose found in fetal fluids (Kim et al., 2012) , glucose is essential for use by trophoblast as an energy source for energy-dependent active AA transporters (Hay, 2006) . Additionally, the placenta metabolizes glucose to fructose via the aldose reductase pathway, thereby supplying fructose as the main hexose sugar to the developing embryo (Meznarich et al., 1987) .
The protein kinase mTOR is responsible for regulating cell growth and proliferation or autophagy and is directly activated by nutrient (glucose) presence and inactivated when nutrients are not present (Tan and Miyamoto, 2016; Wang et al., 2016) . In the conceptus, glucose activates mTOR through the conversion of glucose-6-phosphate to fructose-6-phosphate, then metabolism by glutamine-fructose-6-phosphate transaminase 1 (GFPT-1). Metabolism by GFPT-1 activates the mTOR signaling cascade, which increases cellular proliferation and autophagy during critical time windows such as implantation and maternal recognition of pregnancy (Wang et al., 2016) . Therefore, it is of utmost importance for glucose to be present in the uterine environment and readily available for the conceptus to utilize for activation of mTOR in a concerted effort to increase conceptus proliferation and growth.
In conclusion, these data support our hypothesis that GLUT3 and GLUT14 are present in beef heifer uteroplacental tissues from d 16 to 50. Additionally, GLUT3 was differentially expressed in all tissues, and GLUT14 was differentially expressed in CAR from d 16 to 50 of gestation. No effect of nutritional treatment was found on GLUT3 or GLUT14 expression. These data have established the presence of GLUT3 in beef heifer uteroplacental tissues and are the first to isolate GLUT14 in ruminant uteroplacental tissue. Further research should be conducted to determine the exact cellular location of GLUT14 in uteroplacental tissues, as well as determine its substrate preferences and affinities. This would better define the role that GLUT14 plays in supplying glucose for the establishment and maintenance of pregnancy.
